Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

This policy directs Canadians’ provincial or territorial healthcare plans to cover services considered medically necessary, whether provided by a physician or a physician-equivalent, like a nurse ...

As a national newsroom with roughly 635 journalists working on news and podcasts, NPR cannot claim that it is too small to cover all the important stories of the day. And yet, compared with The New ...

The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug Zepbound for obstructive sleep apnea, reported Annika Kim ...